Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Adaptimmune Therapeutics PLC (ADAP) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/10/2023 4 Menzel Garry E (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 47,702 shares @ $0.9108, valued at $43.4k
07/05/2023 4 Hegde Priti (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 226,464 options to buy @ $0
Granted 109,746 options to buy @ $0
Granted 152,376 options to buy @ $0
07/05/2023 4 Allen Andrew R (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 73,212 options to buy @ $0
Granted 56,868 options to buy @ $0
Granted 45,348 options to buy @ $0
Granted 109,746 options to buy @ $0
Granted 152,376 options to buy @ $0
07/05/2023 4 Menzel Garry E (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 736,548 options to buy @ $0
Granted 1,251,966 options to buy @ $0
Granted 359,700 options to buy @ $0
Granted 3,568,026 options to buy @ $0
Granted 57,846 options to buy @ $0
Granted 2,715,816 options to buy @ $0
Granted 2,158,776 options to buy @ $0
07/03/2023 4 Behbahani Ali (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 933,317 options to buy @ $0
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Menzel Garry E (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 981,463 options to buy @ $0
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Alleva Lawrence M (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 1,077,756 options to buy @ $0
07/03/2023 4 MOTT DAVID M (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 1,462,927 options to buy @ $0
07/03/2023 4 Allen Andrew R (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 500,000 options to buy @ $0
06/01/2023 4 Menzel Garry E (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 200,646 shares @ $0
Granted 200,647 shares @ $0
Granted 209,931 shares @ $0
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy